{"possibly_sensitive": false, "in_reply_to_user_id": "594419534", "referenced_tweets": [{"type": "replied_to", "id": "1246372673929633793"}], "reply_settings": "everyone", "id": "1246373338554888192", "created_at": "2020-04-04T09:45:35.000Z", "public_metrics": {"retweet_count": 0, "reply_count": 1, "like_count": 0, "quote_count": 0}, "context_annotations": [{"domain": {"id": "123", "name": "Ongoing News Story", "description": "Ongoing News Stories like 'Brexit'"}, "entity": {"id": "1220701888179359745", "name": "COVID-19"}}], "author_id": "594419534", "source": "Twitter Web App", "text": "There is potential for making monoclonal antibodies for patients by immunizing animals. Antibody engineering is promising! The other way is to extract antibodies from recovered patients and sequence genes coding for them. We can be hopeful. Webinar by @India_Alliance on #Corona", "entities": {"hashtags": [{"start": 271, "end": 278, "tag": "Corona"}], "mentions": [{"start": 252, "end": 267, "username": "India_Alliance", "id": "2904435062"}]}, "lang": "en", "conversation_id": "1246354328547282945"}